首页> 外文期刊>China National Journal of New Gastroenterology >Establishment and application of experimental model of human fetal hepatocytes: protective effects of silybin and polyporus umbellalus polysac-charides on human fetal hepatocytes
【24h】

Establishment and application of experimental model of human fetal hepatocytes: protective effects of silybin and polyporus umbellalus polysac-charides on human fetal hepatocytes

机译:人胎儿肝细胞实验模型的建立和应用:水飞蓟宾和猪poly多糖对人胎儿肝细胞的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

AIM To establish a new experimental model system with human fetal hepatocytes to study the mechanisms of protective effect of silybin and polyporus umbellalus polysaccharides (PSP) on the ultrastructure of human fetal hepatocytes. METHODS The hepatocytes were obtained from the liver of human fetus from induced labor with written consent. The primarily cultured hepatocytes were pre-treated with silybin and PSP and exposed to CCl_4 for 4 hours. The ultrastructural changes of hepatocytes were observed under scanning electronmicroscopy (SEM) and transmission electronmicroscope (TEM). Transam-inase and SOD were also assayed at the end of culture. RESULT The levels of ALT and AST were significantly decreased and the SOD level elevated in two pretreated groups as compared with that in the control group. The cellular integrity and ultrastructure of hepatocytes were well preserved in the two drugs pretreated groups while they were seriously damaged in the control group. CONCLUSION The experimental model system with human fetal hepatocytes pretreated with CCl_4 could act as an effective method for studying the protective effect of drugs on human hepatocytes, and could be used for screening the medicines for treatment of hepatitis.
机译:目的建立人胎儿肝细胞实验模型系统,研究水飞蓟宾和猪por多糖(PSP)对人胎儿肝细胞超微结构的保护作用机制。方法肝细胞是从人胎儿的肝脏中经书面同意经引产而获得的。将最初培养的肝细胞用水飞蓟宾和PSP预处理,并暴露于CCl_4 4小时。在扫描电镜(SEM)和透射电镜(TEM)下观察肝细胞的超微结构变化。在培养结束时还测定了转氨酶和SOD。结果与对照组相比,两个预处理组的ALT和AST水平显着降低,SOD水平升高。在两个药物预处理组中,肝细胞的细胞完整性和超微结构得到了很好的保存,而在对照组中则受到了严重破坏。结论采用CCl_4预处理的人胎肝细胞实验模型系统可作为研究药物对人肝细胞保护作用的有效方法,可用于筛选治疗肝炎的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号